Vertex Pharmaceuticals 8-K
Leadership change
Daniel Brennan joins the board and Audit and Finance Committee with a $400K RSU award vesting in October 2027.
Filed 2026-10-20 16:09 ET
- 5.02 Officer/director change
Summary
Board appointment. Daniel Brennan joined Vertex’s board and Audit and Finance Committee on 10/20/2026, increasing the board from 10 to 11 members. He received a $400,000 restricted stock unit award that vests in 10/2027.
The summary is written by an AI model reading the filing.
Model 005 · prompt v95 · 2026-10-20 22:38:50Z